ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2019, Volume 70, Issue 2, 442-444

https://doi.org/10.37358/RC.19.2.6931

Adrian Apostol, Lazar Chisavu, Nicolae Albulescu, Dana Stoian, Adalbert Schiller

RAS Inhibition in Haemodyalisis Patients. Impact on mortality

Abstract:

Patients with chronic kidney disease (CKD) represent a special category of risk. As part of the renal and cardiovascular continuum from risk factors to end stage diseases, they develop clinical syndromes with potentially severe prognosis. Patients on dialysis have severe cardiac risk, have a peculiar hyperlipemic profile with intense atherogenic effect, phosphocalcic metabolic alterations and thus a higher rate of development of atheroma and degenerative valve diseases. They have higher cardiovascular mortality and morbidity being potential candidates for aggressive reduction of risk factors. Dialysate patients are exposed to higher risk of ischemic and arrhythmic events. Echocardiographic assessment of these patients is extremely important in risk stratification and treatment strategy in order to improve prognosis. Drugs proved to improve cardiac remodeling, reduce hypertrophy and LV mass and enhance ejection fraction, improved prognosis.
Keywords:
chronic kidney disease; hemodialysis; cardiovascular risk

Issue: 2019, Volume 70, Issue 2
Pages: 442-444
Publication date: 2019/3/15
https://doi.org/10.37358/RC.19.2.6931
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
APOSTOL, A., CHISAVU, L., ALBULESCU, N., STOIAN, D., SCHILLER, A., RAS Inhibition in Haemodyalisis Patients. Impact on mortality, Rev. Chim., 70(2), 2019, 442-444.

Vancouver
Apostol A, Chisavu L, Albulescu N, Stoian D, Schiller A. RAS Inhibition in Haemodyalisis Patients. Impact on mortality. Rev. Chim.[internet]. 2019 Feb;70(2):442-444. Available from: https://doi.org/10.37358/RC.19.2.6931


APA 6th edition
Apostol, A., Chisavu, L., Albulescu, N., Stoian, D. & Schiller, A. (2019). RAS Inhibition in Haemodyalisis Patients. Impact on mortality. Revista de Chimie, 70(2), 442-444. https://doi.org/10.37358/RC.19.2.6931


Harvard
Apostol, A., Chisavu, L., Albulescu, N., Stoian, D., Schiller, A. (2019). 'RAS Inhibition in Haemodyalisis Patients. Impact on mortality', Revista de Chimie, 70(2), pp. 442-444. https://doi.org/10.37358/RC.19.2.6931


IEEE
A. Apostol, L. Chisavu, N. Albulescu, D. Stoian, A. Schiller, "RAS Inhibition in Haemodyalisis Patients. Impact on mortality". Revista de Chimie, vol. 70, no. 2, pp. 442-444, 2019. [online]. https://doi.org/10.37358/RC.19.2.6931


Text
Adrian Apostol, Lazar Chisavu, Nicolae Albulescu, Dana Stoian, Adalbert Schiller,
RAS Inhibition in Haemodyalisis Patients. Impact on mortality,
Revista de Chimie,
Volume 70, Issue 2,
2019,
Pages 442-444,
ISSN 2668-8212,
https://doi.org/10.37358/RC.19.2.6931.
(https://revistadechimie.ro/Articles.asp?ID=6931)
Keywords: chronic kidney disease; hemodialysis; cardiovascular risk


RIS
TY - JOUR
T1 - RAS Inhibition in Haemodyalisis Patients. Impact on mortality
A1 - Apostol, Adrian
A2 - Chisavu, Lazar
A3 - Albulescu, Nicolae
A4 - Stoian, Dana
A5 - Schiller, Adalbert
JF - Revista de Chimie
JO - Rev. Chim.
PB - Revista de Chimie SRL
SN - 2668-8212
Y1 - 2019
VL - 70
IS - 2
SP - 442
EP - 444
UR - https://doi.org/10.37358/RC.19.2.6931
KW - chronic kidney disease
KW - hemodialysis
KW - cardiovascular risk
ER -


BibTex
@article{RevCh2019P442,
author = {Apostol Adrian and Chisavu Lazar and Albulescu Nicolae and Stoian Dana and Schiller Adalbert},
title = {RAS Inhibition in Haemodyalisis Patients. Impact on mortality},
journal = {Revista de Chimie},
volume = {70},
number = {2},
pages = {442-444},
year = {2019},
issn = {2668-8212},
doi = {https://doi.org/10.37358/RC.19.2.6931},
url = {https://revistadechimie.ro/Articles.asp?ID=6931}
}
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice